As of 2025-12-12, the Relative Valuation of Apellis Pharmaceuticals Inc (APLS) is 8.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.96 USD, the upside of Apellis Pharmaceuticals Inc based on Relative Valuation is -66.6%.
The range of the Relative Valuation is 6.60 - 11.16 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 22.9x | 20.8x |
| Forward P/E multiples | 20.9x - 31.4x | 26.2x |
| Fair Price | 6.60 - 11.16 | 8.34 |
| Upside | -73.6% - -55.3% | -66.6% |
| Date | P/E |
| 2025-12-09 | 66.88 |
| 2025-12-08 | 66.91 |
| 2025-12-05 | 66.46 |
| 2025-12-04 | 62.41 |
| 2025-12-03 | 59.77 |
| 2025-12-02 | 58.11 |
| 2025-12-01 | 59.63 |
| 2025-11-28 | 59.91 |
| 2025-11-26 | 60.73 |
| 2025-11-25 | 59.07 |
| 2025-11-24 | 56.62 |
| 2025-11-21 | 55.16 |
| 2025-11-20 | 54.96 |
| 2025-11-19 | 54.71 |
| 2025-11-18 | 55.49 |
| 2025-11-17 | 56.53 |
| 2025-11-14 | 57.18 |
| 2025-11-13 | 55.72 |
| 2025-11-12 | 56.31 |
| 2025-11-11 | 54.87 |
| 2025-11-10 | 53.44 |
| 2025-11-07 | 54.17 |
| 2025-11-06 | 55.44 |
| 2025-11-05 | 56.11 |
| 2025-11-04 | 57.58 |
| 2025-11-03 | 58.19 |
| 2025-10-31 | 60.39 |
| 2025-10-30 | 58.31 |
| 2025-10-29 | 84.52 |
| 2025-10-28 | 84.52 |
| 2025-10-27 | 83.76 |
| 2025-10-24 | 79.23 |
| 2025-10-23 | 80.47 |
| 2025-10-22 | 79.15 |
| 2025-10-21 | 79.63 |
| 2025-10-20 | 76.14 |
| 2025-10-17 | 68.97 |
| 2025-10-16 | 67.93 |
| 2025-10-15 | 70.94 |
| 2025-10-14 | 65.11 |
| 2025-10-13 | 67.90 |
| 2025-10-10 | 70.65 |
| 2025-10-09 | 72.37 |
| 2025-10-08 | 70.09 |
| 2025-10-07 | 70.91 |
| 2025-10-06 | 68.52 |
| 2025-10-03 | 66.94 |
| 2025-10-02 | 65.00 |
| 2025-10-01 | 64.97 |
| 2025-09-30 | 63.65 |